AlloDerm Versus Cortiva: A Multicenter Pooled Analysis of Clinical and Economic Outcomes in Breast Reconstruction.

ABSTRACT:

Background

AlloDerm and Cortiva are 2 commonly used human acellular dermal matrices for prosthetic breast reconstruction, yet their comparative clinical performance remains uncertain. The objective of this study is to systematically compare short-term clinical outcomes, patient-reported physical well-being, and perioperative resource use among AlloDerm and Cortiva in immediate or delayed prosthetic breast reconstruction.

Methods

A systematic search of PubMed, Scopus, and Web of Science (from inception to June 15, 2025) identified comparative studies of AlloDerm versus Cortiva. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines were followed. Studies were included if they provided comparative data on complications, BREAST-Q scores, or costs

SUBMITTER: Tanas Y 

PROVIDER: S-EPMC12912061 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature